FDA
approval
· 2023-03-31
FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for a generic sumatriptan succinate product from Mylan Pharmaceuticals Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)